- Home
- PLCE vs CNTX Comparison
PLCE vs CNTX Comparison
Compare PLCE & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- CNTX
- Stock Information
- Founded
- PLCE 1969
- CNTX 2015
- Country
- PLCE United States
- CNTX United States
- Employees
- PLCE N/A
- CNTX N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- PLCE Consumer Discretionary
- CNTX Health Care
- Exchange
- PLCE Nasdaq
- CNTX Nasdaq
- Market Cap
- PLCE 128.9M
- CNTX 78.0M
- IPO Year
- PLCE 1997
- CNTX 2021
- Fundamental
- Price
- PLCE $5.76
- CNTX $0.59
- Analyst Decision
- PLCE Hold
- CNTX Strong Buy
- Analyst Count
- PLCE 1
- CNTX 4
- Target Price
- PLCE $9.00
- CNTX $6.00
- AVG Volume (30 Days)
- PLCE 411.4K
- CNTX 167.4K
- Earning Date
- PLCE 06-11-2025
- CNTX 05-07-2025
- Dividend Yield
- PLCE N/A
- CNTX N/A
- EPS Growth
- PLCE N/A
- CNTX N/A
- EPS
- PLCE N/A
- CNTX N/A
- Revenue
- PLCE $1,386,269,000.00
- CNTX N/A
- Revenue This Year
- PLCE N/A
- CNTX N/A
- Revenue Next Year
- PLCE N/A
- CNTX N/A
- P/E Ratio
- PLCE N/A
- CNTX N/A
- Revenue Growth
- PLCE N/A
- CNTX N/A
- 52 Week Low
- PLCE $4.77
- CNTX $0.49
- 52 Week High
- PLCE $19.74
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- PLCE 45.87
- CNTX 29.92
- Support Level
- PLCE $5.60
- CNTX $0.49
- Resistance Level
- PLCE $6.40
- CNTX $0.71
- Average True Range (ATR)
- PLCE 0.37
- CNTX 0.08
- MACD
- PLCE 0.03
- CNTX -0.02
- Stochastic Oscillator
- PLCE 13.22
- CNTX 27.22
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.